National Institutes of Health director Francis Collins said Tuesday that the recent court ruling blocking federally funded research on human embryonic stem cells won't affect grant payments that have already been paid out this year. But the institute will freeze its reviews of new grants of this type. Although California's $3 billion stem cell initiative is not affected, we talk about the ruling and its potential impact on Bay Area biotech.
Labs in Limbo
Dr. David Stevens, chief executive officer of Christian Medical and Dental Associations
Dr. Helen Blau, professor and director of Baxter Laboratory for Stem Cell Biology at Stanford University
Tom Abate, staff writer covering economics for San Francisco Chronicle
Art Torres, former chairman of the California Democratic Party and vice chair for the board at California Institute for Regenerative Medicine